Regulatory Consequences of “Brexit” for the Development of Medicinal Products
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.706
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 27, 2017
Authors
Publisher
Wiley